Low ASNS expression in tumor cells, including certain solid cancers, such as pancreatic ductal adenocarcinomas, could be used to suggest patients the treatment with asparaginase-added chemotherapy. This evidence concerns the gene ASPG and pancreatic ductal adenocarcinoma.